Versatile High Affinity Antibody to DOTA Chelates of Multiple Radionuclides
Exclusively Licensed
Invention type: Technology
/
Case number: #13506
Compositions and methods for the treatment of cancer and infectious disease The compositions include engineered proteins that specifically bind a target (e g, a cellular protein) on a cancerous cell or a pathogen and a metal chelate comprising DOT A, or an active variant thereof, and a metal ion such as a radionuclide are disclosed By virtue of the multiple binding sites, the engineered protein effectively delivers a metal chelate to a cell one wishes to destroy.
Researchers
Karl Dane Wittrup
/
Kelly Davis
Departments: Department of Chemical Engineering
Technology Areas: Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
versatile high affinity antibody to dota chelates of multiple radionuclides
Spain | Granted | 2,403,530 -
engineered proteins with high affinity for dota chelates
United States of America | Granted | 8,648,176 -
versatile high affinity antibody to dota chelates of multiple radionuclides
European Patent Convention | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
Switzerland | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
Italy | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
Ireland | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
United Kingdom | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
Belgium | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
Germany | Granted | 2,403,530 -
versatile high affinity antibody to dota chelates of multiple radionuclides
France | Granted | 2,403,530
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.